A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the ...

Researchers have developed a cancer vaccine method that can target virtually any solid tumor, amplifying the visibility of ...

Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...

Researchers developed a cancer vaccine that uses tumor lysate to enhance immune recognition of solid tumors. The vaccine ...

Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

The new medication is personalized for each patient's tumor, mobilizing the immune system to attack cancer cells with few ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

A vaccine for pancreatic cancer could serve as a promising new therapy. At Memorial Sloan Kettering Cancer Center (MSK) in New York, an experimental approach to treating the cancer with a ...

Out of the 16 patients in the study, half had a strong response to the vaccine. A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a ...